1 Section of Cardiovascular Medicine and Robert Wood Johnson Clinical Scholars Program, Department of Medicine, Section of Health Policy and Administration, School of Public Health, Yale University School of Medicine, PO Box 208088, New Haven, CT 06520-8088, USA
2 Department of Geriatrics and Adult Development, Mount Sinai School of Medicine, New York, USA
Correspondence to: H M Krumholz [email protected]
Competing interests: None declared.
Provenance and peer review: Commissioned; not externally peer reviewed.
The relationship between the drug industry, academia, healthcare professionals, and patients is widely held to be at an all time low, and it is in the interests of all parties to improve it. A report issued by the Royal College of Physicians this week gives 42 recommendations aimed at forging a more productive partnership with industry. Here we set out five views on what the ideal relationship between industry and prescribers and patients should be and what steps need to be taken to achieve it
TELL US YOUR VIEWS. Which view of the relationship between industry, doctors, and patients do you support? Vote on bmj.com
